SBRI Healthcare has announced 10 innovations to be awarded a share of £1 million to fund their development in the fields of cardiovascular disease and the integration of health & social care.
After over 150 applications, 10 innovations have been selected. The projects will run for up to six months, with an aim to demonstrate whether these innovations are technically feasible, before further funding is sought to develop and evaluate prototypes.
The long-term aim is for successful technologies to be adopted for use in the NHS and across social care services where they can provide benefits for patients, the NHS and the overall community.
Lesley Soden, Innovation Programme Director, Health Innovation Network “To achieve the NHS’s ambition to help prevent over 150,000 heart attacks, strokes and dementia cases over the next 10 years we need to embrace advances in products, technology, and artificial intelligence solutions.”
“These cutting-edge projects are leading the way in the field of CVD innovation. It is so exciting as they have the potential to revolutionise patient care for the 7.4 million people living with heart and circulatory diseases in the UK. Alongside the SBRI Healthcare funding we are looking forward to accelerating the use of these proven innovations within NHS’s cardio-vascular services.”
Funding was awarded to the following projects:
Bronze Software Labs Ltd – awarded £100,000: The mission of ‘The Tribe Project’ is to directly address care inequality through closing national social care ‘dark patches’ where services are not currently commissioned or failing. Through use of applied technology, we will improve the quality of life for millions of vulnerable people.
Brain in Hand Ltd – awarded £99,486: Brain in Hand’s unique support system aims to transform the model of care for autistic individuals, helping them to live more independently by providing a digital solution for delivery of personalised care. Enabling support to be more effective and organisations to spread resources further.
Digital Home Visits Technologies Ltd – awarded £99,898: Combining home monitoring with predictive analytics to enable early detection and intervention of respiratory diseases.
Loc8tor Ltd – awarded £98,690: Produce an enhancement strategy for the B2C Wellwise assisted living solution. Meeting statutory requirements and providing next-generation care and efficiencies. Combining key aspects of Safety, Health and ADL (Activities of Daily Living) whilst looking at early identification based on variations to expected behaviour.
Nelus AI Ltd – awarded £99,516: Integration of an outreach hearing test with an AI-enabled BOT to guide patients and clinicians to share the right information with the right people at the right time to ensure early identification and integrated responses to hearing loss and frailty.
Upstream Health – awarded £90,023: Bridgit™ is a support system helping elderly people keep well and independent both within and outside their homes. Using Artificial Intelligence, Internet of Things and 2-way communication, Bridgit™ provides insights and direction, enabling targeted support and engagement of users, families and social care.
AIMES – awarded £99,868: AI enhanced MRI measurement of heart function developed using more than 2m images from 10 diverse sites. The algorithm betters human performance for speed, accuracy and prognostication. Pan-NHS use will change ~20% of major clinical decisions (e.g. ICD insertion).
Ceryx Medical Ltd – awarded £99,960: Ceryx is developing a novel implantable bioelectronics therapeutic device targeting Heart Failure (HF). The technology will arrest, or reverse, HF pathology using a novel technique of modulating heart functions in line with respiration improving efficiency and performance.
Invitron Ltd – awarded £99,636: Invitron is developing a portable device that will perform rapid, accurate diagnostic tests using just a small finger prick of blood. This device will enable heart failure to be diagnosed directly in GP practices within a few minutes.
Oxford Heartbeat Ltd – awarded £100,000: Oxford Heartbeat are developing technology that helps clinicians to accurately plan and rehearse minimally invasive stent graft replacements inside blood vessels with a view to making cardiovascular surgeries more efficient and effective.
